1. Genentech, Inc. (5 from 3,221 patents)

2. Cytokinetics, Inc. (3 from 257 patents)

3. Hoffmann-la Roche Inc. (2 from 4,942 patents)

4. Amgen Inc. (2 from 1,970 patents)

5. F. Hoffmann-la Roche Ag (168 patents)

1. 12410189 - Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9- yl)amino)propanamide, and methods of production

2. 12221417 - Salt of omecamtiv mecarbil and process for preparing salt

3. 11958809 - Salt of omecamtiv mecarbil and process for preparing salt

4. 11780834 - Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

5. 11591345 - Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production

6. 11472773 - Salt of omecamtiv mecarbil and process for preparing salt

7. 11028100 - Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production

8. 10954234 - Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

9. 9988354 - Salt of omecamtiv mecarbil and process for preparing salt

10. 7951368 - Compositions of specific binding agents to hepatocyte growth factor